Total Payments
$2,368
2024 Payments
$209.14
Companies
26
Transactions
153
Medicare Patients
5,938
Medicare Billing
$423,625
Payment Breakdown by Category
Food & Beverage$2,368 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,368 | 153 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $311.19 | 21 | $0 (2024) |
| PFIZER INC. | $300.55 | 20 | $0 (2021) |
| Novo Nordisk Inc | $295.04 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $237.82 | 15 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $212.31 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $205.36 | 12 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.99 | 7 | $0 (2021) |
| BioDelivery Sciences International, Inc. | $88.36 | 6 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $80.72 | 6 | $0 (2023) |
| Astellas Pharma US Inc | $75.23 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $209.14 | 12 | Novartis Pharmaceuticals Corporation ($101.65) |
| 2023 | $127.04 | 8 | Bayer Healthcare Pharmaceuticals Inc. ($29.31) |
| 2022 | $355.47 | 21 | Amgen Inc. ($80.29) |
| 2021 | $276.44 | 18 | AstraZeneca Pharmaceuticals LP ($114.99) |
| 2020 | $362.21 | 23 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($75.24) |
| 2019 | $259.85 | 19 | Amgen Inc. ($121.98) |
| 2018 | $345.88 | 23 | PFIZER INC. ($120.87) |
| 2017 | $431.68 | 29 | PFIZER INC. ($113.08) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Genetic Disease | ||||||
| 04/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Inflammation | ||||||
| 02/29/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Diabetes | ||||||
| 10/19/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardio-renal | ||||||
| 09/21/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Biological | ||||||
| 06/26/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 05/10/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Endocrinology | ||||||
| 04/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Cardio-renal | ||||||
| 03/16/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: VACCINES | ||||||
| 02/16/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiology | ||||||
| 10/12/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardio-renal | ||||||
| 10/05/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| Category: Cardiovascular | ||||||
| 09/21/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Cardiology | ||||||
| 09/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,470 | 2,398 | $252,552 | $105,146 |
| 2022 | 21 | 1,449 | 2,499 | $264,771 | $111,828 |
| 2021 | 20 | 1,527 | 2,745 | $273,103 | $110,517 |
| 2020 | 23 | 1,492 | 2,620 | $266,681 | $96,134 |
Total Patients
5,938
Total Services
10,262
Medicare Billing
$423,625
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 175 | 414 | $107,640 | $48,682 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 314 | $65,940 | $23,450 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 107 | $15,515 | $5,423 | 35.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 253 | 592 | $6,512 | $4,973 | 76.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 139 | 142 | $7,705 | $4,743 | 61.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 139 | 142 | $7,810 | $4,195 | 53.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $4,800 | $3,209 | 66.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $5,400 | $2,380 | 44.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 152 | 153 | $10,557 | $2,306 | 21.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 36 | 49 | $6,860 | $2,272 | 33.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 152 | 153 | $7,038 | $1,529 | 21.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 68 | 156 | $3,900 | $1,485 | 38.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 21 | 79 | $2,370 | $408.05 | 17.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 31 | $217.00 | $68.20 | 31.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 32 | $288.00 | $24.07 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 158 | 364 | $94,640 | $43,677 | 46.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 197 | 362 | $76,020 | $26,217 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 145 | $21,025 | $8,091 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 29 | $8,700 | $4,377 | 50.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 136 | 138 | $5,520 | $4,356 | 78.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 136 | 138 | $7,590 | $3,895 | 51.3% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 15 | 15 | $3,975 | $3,757 | 94.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 59 | $7,375 | $3,111 | 42.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 13 | $3,900 | $2,779 | 71.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $2,100 | $1,845 | 87.8% |
About Dr. Paul Gering, MD
Dr. Paul Gering, MD is a Family Medicine healthcare provider based in Ontario, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235198995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Gering, MD has received a total of $2,368 in payments from pharmaceutical and medical device companies, with $209.14 received in 2024. These payments were reported across 153 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,368).
As a Medicare-enrolled provider, Gering has provided services to 5,938 Medicare beneficiaries, totaling 10,262 services with total Medicare billing of $423,625. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Ontario, OR
- Active Since 03/21/2006
- Last Updated 12/01/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235198995
Products in Payments
- ELIQUIS (Drug) $205.36
- FARXIGA (Drug) $196.27
- LYRICA (Drug) $149.48
- ENTRESTO (Drug) $140.78
- Aimovig (Biological) $130.17
- Ozempic (Drug) $109.42
- Victoza (Drug) $107.40
- Kerendia (Drug) $80.72
- BELBUCA (Drug) $72.82
- LEQVIO (Drug) $71.53
- Otezla (Drug) $71.27
- STIOLTO RESPIMAT (Drug) $67.52
- VIAGRA (Drug) $58.40
- EUCRISA (Drug) $55.02
- Repatha (Biological) $54.82
- Rybelsus (Drug) $52.84
- EVENITY (Biological) $41.38
- Livalo (Drug) $40.38
- VRAYLAR (Drug) $40.29
- STIOLTO (Drug) $34.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ontario
Renu Bhupathy, M.d, M.D
Family Medicine — Payments: $18,525
Family Medicine $18,525
Harold Brown, Do, DO
Family Medicine — Payments: $15,100
Family Medicine $15,100
Dr. Gordon Long, M.d, M.D
Family Medicine — Payments: $14,963
Family Medicine $14,963
Edward Adkins, M.d, M.D
Family Medicine — Payments: $14,470
Family Medicine $14,470
Melissa Becker, Md, MD
Family Medicine — Payments: $5,465
Family Medicine $5,465
Dr. Charles Ho, M.d, M.D
Family Medicine — Payments: $2,949
Family Medicine $2,949